Pin Therapeutics
PrivateLast Round
Series C
Dec 23, 2024
Est. Valuation
$83.86M
Total Funding Raised
$49.71M
Momentum Score
50 /100
Company Overview
Pin Therapeutics is a biotechnology company that develops therapeutic drugs using targeted protein degradation technology to treat diseases like cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pin Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Pin Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 23, 2024 | ||||
| Series B | Feb 21, 2022 | ||||
| Debt | Mar 15, 2021 | ||||
| Series A | Aug 28, 2019 |
Pin Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KDB Capital Corp | Series C |
| DSC Investment | Series B, Series C, Debt |
| KB Investment | Series B, Series C, Debt |
| Company K Partners | Series B |
| K-Run Ventures | Series A |
| Hyundai Technology Investment | Series A |
| L&S Venture Capital | Series A |
Pin Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pin Therapeutics's valuation, stock price, and market status.
